Inovio Pharmaceuticals Inc (INO)

[cameron12x]

I agree with you.

IMHO, at the end of the day, it's ALL going to be about combination therapies to achieve the desired outcomes.

I see Inovio leading the way with the delivery mechanism (electroporation) and providing the robust T-cell uptake needed. As well as basic research using synthetic DNA to add to their platform and patent portfolio. Other players can handle the rest.

That's why in the short-term we will likely need to partner and also why big pharma will need to partner with us. New partnerships WILL happen, or we will be purchased for north of $10B within two years, IMHO.